Mindray Medical (NYSE:MR) said today it completed the acquisition of the remaining stakes in Wuhan Dragonbio for a price of approximately $70.2 million. Shenzhen, China-based Mindray manufactures and markets patient monitoring and life support devices, in-vitro diagnostics and medical imaging systems, the company said. Mindray now holds 100% of the shares of Dragonbio, producer of orthopedic products […]
Wuhan Dragonbio Surgical Implants
Mindray buys remaining stake in Dragonbio
Mindray Medical (NYSE:MR) said today it is acquiring the remaining stake in Wuhan Dragonbio for an estimated $72.6 million. Shenzhen, China-based Mindray manufactures and markets patient monitoring and life support devices, in-vitro diagnostics and medical imaging systems, the company said. “Since we acquired a majority stake of Dragonbio in 2012, the integration has been well on […]